Performance evaluation of cefoxitin screen test on two different automated antimicrobial susceptibility test systems: a comparative study
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.03815-23 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Ismail Yuceel-Timur und 3 weiteren Autor:innen. Beteiligte Einrichtung: Global Medical Affairs, bioMérieux, Lyon, France. Hauptthemen laut MEDLINE: Cefoxitin, Microbial Sensitivity Tests, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Reliable detection of mec A and mec C-mediated beta-lactam resistance using automated antimicrobial susceptibility test systems is critical for patient care. The aim of this study was to compare the performance of the new cefoxitin screen test (oxsf02n) on the Vitek 2 card (Vitek 2) and BD Phoenix PMC-100 Gram-Positive AST Panel (Phoenix) against the reference method for the detection of mec A (and mec C)-mediated beta-lactam resistance. Two hundred fifty clinical fresh and stock Staphylococcus spp. isolates were included. There were 120 mec A-positive, 10 mec C-positive, and 120 mec A and mec C-negative isolates. Cefoxitin screen and oxacillin tests were performed on Vitek 2 and Phoenix and by their respective reference methods (disk diffusion for the cefoxitin screen test and broth microdilution for oxacillin) for all isolates. PCR testing was also performed to confirm the presence of mec A and/or mec C genes. Results from each system were compared to the reference methods. Statistical hypotheses were evaluated both for Vitek 2 compared to the reference methods and Vitek 2 compared to the Phoenix. Compared to the reference method, the Vitek 2 cefoxitin screen test had 100% sensitivity/98% specificity and the Phoenix cefoxitin screen test had 84% sensitivity/100% specificity for the detection of mec A (and mec C)-mediated beta-lactam resistance. When the oxacillin test was combined with the cefoxitin screen for Vitek 2, the sensitivity and specificity were unchanged. However, when the oxacillin and cefoxitin screen tests were combined for the Phoenix, the sensitivity increased to 100% and the specificity remained unchanged (100%). When considering cefoxitin alone, the Vitek 2 screen test showed a higher sensitivity than the Phoenix for the detection of mec A and mec C-mediated beta-lactam resistance. However, currently, both systems use a combination of the cefoxitin and oxacillin tests to interpret the final result, and both reached a high level of performance when cefoxitin and oxacillin results were combined. IMPORTANCE This research marks the inaugural evaluation of the revamped cefoxitin screen test version in Vitek 2, juxtaposing it against reference methods and a primary competitor BD Phoenix.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Global Medical Affairs, bioMérieux, Lyon, France.
- Global Medical Affairs, bioMérieux, Hazelwood, Missouri, USA.
- Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
ORCID-Profile: Ismail Yuceel-Timur, Cherilyn D Garner
Zitieren
APA
Yuceel-Timur, I., Garner, C. D., Franklin, S., & Hardy, D. J. (2024). Performance evaluation of cefoxitin screen test on two different automated antimicrobial susceptibility test systems: a comparative study. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03815-23
Vancouver
Yuceel-Timur I, Garner CD, Franklin S, Hardy DJ. Performance evaluation of cefoxitin screen test on two different automated antimicrobial susceptibility test systems: a comparative study. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03815-23
BibTeX
@article{YuceelTimur2024,
author = {Yuceel-Timur, Ismail and Garner, Cherilyn D and Franklin, Simone and Hardy, Dwight J},
title = {Performance evaluation of cefoxitin screen test on two different automated antimicrobial susceptibility test systems: a comparative study},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.03815-23}
}
EUVIMED